Effects on gastric prostaglandin synthesis produced by fenbufen, a new nonsteroidal anti-inflammatory agent with low gastrointestinal toxicity.
D000818:Animals; D000893:Anti-Inflammatory Agents / Q000009:adverse effects / Q000494:pharmacology*; D004064:Digestive System / Q000187:drug effects*; D005753:Gastric Mucosa / Q000378:metabolism*; D006168:Guinea Pigs; D006801:Humans; D007213:Indomethacin / Q000009:adverse effects / Q000378:metabolism; D010648:Phenylacetates / Q000494:pharmacology; D010654:Phenylbutyrates; D010974:Platelet Aggregation / Q000187:drug effects; D011422:Propionates / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology*; D011453:Prostaglandins / Q000096:biosynthesis*
D000893:Anti-Inflammatory Agents; D010648:Phenylacetates; D010654:Phenylbutyrates; D011422:Propionates; D011453:Prostaglandins; C012776:biphenylylacetic acid; C010725:fenbufen; D007213:Indomethacin